Buğra Han Egeli

Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever

Serdal Uğurlu, B. Ergezen, Buğra Han Egeli et al. · Lara D. Veeken · 2020 · 35 citations · Full text

Medicine, Immunology, Pharmacotherapy +11

Familial Mediterranean fever: clinical state of the art

Buğra Han Egeli, Serdal Uğurlu · QJM · 2020 · 28 citations

Life Sciences, Clinical Sciences, Immunology +14

Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience

Serdal Uğurlu, B. Ergezen, Buğra Han Egeli et al. · Lara D. Veeken · 2020 · 21 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO)

Yongdong Zhao, Melissa Oliver, Anja Schnabel et al. · Annals of the Rheumatic Diseases · 2025 · 14 citations

Medicine, Orthopaedic Surgery, Pediatrics +8

The clinical role of anakinra in the armamentarium against familial Mediterranean fever

Kerem Parlar, Muhammed Bahaddin Ates, Buğra Han Egeli et al. · Expert Review of Clinical Immunology · 2023 · 12 citations

Medicine, Immunology, Pharmacology +17